Adverum Biotechnologies, Inc.

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+230 K	97.4%	$1.35	+$311 K
Sells	1	-6.2 K	2.6%	$1.52	-$9.43 K
Net	+1	+224 K	94.7%		+$301 K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Laurent Fischer	CEO, PRESIDENT AND DIRECTOR, Director	$1.07 M			Feb 12, 2024
Peter Soparkar	Chief Operating Officer	$412 K			Feb 12, 2024
Julie Clark	Chief Medical Officer	$255 K			Sep 30, 2021
Angela Thedinga	Chief Technology Officer	$232 K			Aug 6, 2021
Brigit Riley	Chief Scientific Officer	$182 K			Mar 15, 2023
Mark Lupher Jr.	Director	$176 K	+$176 K		Jun 17, 2024
Linda M. Rubinstein	Chief Financial Officer	$155 K			Feb 12, 2024
James Scopa	Director	$140 K	+$135 K	+2999%	Jun 17, 2024
John Rakow	SVP, Genl Counsel, Acting CFO	$90.2 K			Sep 14, 2022
Setareh Seyedkazemi	Chief Development Officer	$73.8 K	-$9.43 K	-11.3%	Feb 12, 2024
Richard Beckman	Chief Medical Officer	$60.5 K			Mar 1, 2023
Rupert D'Souza	Chief Financial Officer	$32.3 K			May 13, 2022
Soo Hong	Director				Jun 17, 2024
Jack Anthony Thrift	Interim CFO				Sep 2, 2021
Reed Vaughn Tuckson	Director				Jun 17, 2024
Patrick Machado	Director				Jun 17, 2024
Scott M. Whitcup	Director				Jun 17, 2024
C. David Nicholson	Director				Jun 17, 2024
Christopher DeRespino	Acting Chief Financial Officer and Chief Business Officer				Jun 24, 2021
Szilard Kiss	Director				Jun 17, 2024
Dawn Svoronos	Director				Jun 17, 2024
Rabia Gurses Ozden	Chief Medical Officer				Jun 17, 2024
Nancy Pecota	Principal Accounting Officer				Jun 6, 2022
Mehdi Gasmi	Director				May 12, 2021
Thomas Woiwode	Director				May 12, 2021

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership